National Research Corporation·Healthcare

SMR's dual NRC Part 52 approvals give it a licensing head start that could speed deployments for AI sites and industry.

The nuclear sector is delivering concrete progress on multiple advanced reactor programs. Recent weeks brought a positive environmental determination for an X-energy (XE) project, Nuclear Regulatory Commission (NRC) approvals for key technical documents from Oklo (OKLO) and Terrestrial Energy (IMSR), and the start of prototype manufacturing for critical reactor components.

Represents a key milestone on the project's NRC Construction Permit Application Project supported by U.S. DOE's Advanced Reactor Demonstration Program MIDLAND, Mich. and ROCKVILLE, Md.

Edmonton, Alberta – May 13, 2026 - TheNewswire – Innovotech Inc. (TSX Venture Exchange: IOT ; OTCQB: IOTCF ) (“Innovotech” or the “Company”) reports that its subsidiary Innovotech Labs Corporation is receiving advisory services and research and development funding of up to $234,000 CAD from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) to support the development of new antimicrobial testing services for use with medical devices such as catheters, implants, and wound dressings. The new testing methods align with changes in international regulatory standards and medical device manufacturers' needs in the areas of proliferation, biofilm formation, and translocation of microorganisms. This work builds on foundational development started last year and advances it into more robust, fit-for-purpose testing. As customer programs expand, manufacturers are requesting more advanced testing that better reflects real-world use and provides clearer decision-making data. Strengthening these capabilities will expand the Company service offerings, support regulatory readiness, and help customers demonstrate device safety and performance more effectively.

Vancouver, British Columbia--(Newsfile Corp. - May 13, 2026) - Nations Royalty Corp. (TSXV: NRC) (OTCQX: NRYCF) (FSE: Y96) ("Nations Royalty" or the "Company") is pleased to announce that it has granted, effective May 12, 2026, incentive stock options to certain directors, officers, employees, and consultants of the Company to acquire an aggregate of 934,000 common shares in the capital of the Company at an exercise price of $0.955 (the "Options"), being the closing price of the Company's common shares on the TSX Venture Exchange on May 12, 2026. The Options are exercisable for a period of five (5) years from the date of grant and will vest as follows: one-third (1/3) on the date of grant, one-third (1/3) after 12 months, and the remaining one-third (1/3) after 24 months from the date of grant.

NRC Health (NRC) Q1 2026 Earnings Call Transcript
National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, health risk assessments, employee engagement, reputation management, and brand loyalty. The company also offers market insights solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. In addition, it provides experience solutions, such as patient and resident experience, workforce engagement, health risk assessments, transitions, and improvement tools. Further, the company offers health risk assessment solutions that enable clients to segment populations and manage care for those who are most at risk, engage individuals, enhance preventative care, and manage wellness programs; and transitions solutions, which enable organizations to identify and manage high-risk patients to reduce readmissions, enhance patient satisfaction and support safe care transitions. Additionally, it provides transparency solutions that allow healthcare organizations to share picture of their organization and ensure content informs in consumer decision-making; and governance solutions for not-for-profit hospital and health system boards of directors, executives, and physician leadership. The company serves integrated health systems, post-acute providers, and payer organizations. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska.
Healthcare
Medical - Healthcare Information Services
368
2013-05-23
0.34